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Abstract
Background: Chylothorax is a relatively rare but well-known complication of thoracic surgery.
Case Presentation: A 70-year-old man underwent right upper and middle bilobectomy and systematic lymph
node dissection through a posterolateral thoracotomy for lung cancer. On the second postoperative day, he
developed chylothorax that was treated with dietary management and pleurodesis. The discharge diminished and
his chest tube was removed on the ninth postoperative day. On the 14th postoperative day, the patient complained
of dyspnea and dysphagia, and imaging studies revealed mediastinal chyloma. Thoracoscopic surgical drainage was
performed and the site of chyle leakage was sutured.
Conclusions: This report presents an unexpected complication of chemical pleurodesis and reviews the indications
for surgical intervention in cases of postoperative chylothorax.
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Background
Chylothorax is a relatively rare but well-known complication
of thoracic surgery. It is treated with some conservative
approaches such as oral intake cessation including nil per os
with total parenteral nutrition, low-fat diet management, and
chemical pleurodesis [1]. Surgical intervention is considered
only when conservative treatments have failed. We report a
case of mediastinal chyloma possibly induced by pleurodesis
to treat chylothorax following lung cancer surgery.
Case presentation
A70-year-oldmanwas diagnosedwith lung adenocarcinoma
(clinical T4N0M0) involving a right upper lobe mass of
4.0 cm in diameter and a metastatic nodule in the middle
lobe. He underwent right upper andmiddle bilobectomy and
systematic lymph node dissection through a posterolateral
thoracotomy. On the second postoperative day, 1750 mL of
white turbid fluid was drained through the chest tube and
the effusion was diagnosed as chylothorax. During the first
24 h following implementation of a fat-free dietary regimen,
the color of the discharge became transparent, but another
630 mL of discharge was observed. Although the amount of
discharge reduced gradually, it was persistent. Chemical
pleurodesis was performed on the sixth postoperative day for
which 5 KE of OK-432 (Picibanil; Chugai Pharmaceutical,
Tokyo, Japan) and 300 mg of minocycline were administered
into the thoracic cavity. The discharge began to progressively
diminish. Three days thereafter, the amount of discharge had
decreased to 150 mL/day, and on the ninth postoperative day,
the chest tube was removed. On the 14th postoperative day,
the patient complained of dyspnea and dysphagia, and an
upper mediastinal mass was detected on chest radiogram
(Fig. 1). Chest computed tomography revealed a largemedias-
tinal fluid collection 6 cm in diameter surrounded by a thick
capsule that was compressing the trachea and esophagus
(Fig. 2). The mass was suspected to be a mediastinal chyloma.
Since the patient’s symptoms were gradually progressing, we
performed surgery on the 15th postoperative day. Thirty mi-
nutes before the surgery, ice creamwas given to the patient to
help confirm the leakage point in the thoracic duct. Thoraco-
scopy revealed a small amount of chylous effusion in the thor-
acic cavity and an elastic mass in the upper mediastinum.
When the thick capsule was incised, chyle began to spill out
(Fig. 3a, b). Once the chyle had drained completely, we con-
firmed the point of leakage and repaired it using a Z-suture
with 4–0 Prolene (Ethicon, Somerville, NJ) (Fig. 3c, d). The
postoperative course was uneventful and the patient was free
of any symptoms. He remained asymptomatic 12 months
after discharge from the hospital.
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Discussion
Chylothorax after lung cancer surgery is relatively rare,
occurring in only 2.2–2.4 % of cases [1–3]. Management
strategies for chylothorax have been well discussed, but
so far there is no consensus as to protocol. Traditionally,
chylothorax is treated conservatively with dietary modifi-
cation. The basic principle of conservative treatment for
chylothorax is to inflate the remnant lung to decrease
the dead space and to promote spontaneous adhesion
around the injured thoracic duct [2]. Cerfolio et al. [4]
recommended observation of the patient for seven days
with dietary management. At that point, if the drainage
is still greater than 1000 mL/day, reoperation to ligate
the thoracic duct is necessary. In cases where dietary
management are insufficient, pleurodesis must be con-
sidered. Since the amount of chylous fluid may reduce
the efficacy of pleurodesis, Shimizu et al. [2] recom-
mended early surgical intervention if chest tube drainage
Fig. 1 Chest radiography showing upper mediastinal mass
Fig. 2 Chest computed tomography showing a large mediastinal fluid collection surrounded by a thick capsule that is compressing the trachea
and esophagus
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of more than 500 mL of chylous fluid was observed dur-
ing the first 24 h after complete oral intake cessation
and the initiation of total parenteral nutrition. It should
also be noted that pleurodesis has the potential to make
subsequent surgery more difficult. In fact, in this case
we found several fibrous adhesions around the remnant
lower lobe during the second surgery, which could even-
tually lead to chyloma formation. Suzuki et al. [5] like-
wise reported a case of a mediastinal chyloma after a
conservative treatment with OK-432 following right
upper lobectomy and systematic lymph node dissection.
They reported that the thick capsule of the chyloma may
have been the results of severe inflammation response
caused by the intrapleural injection of OK-432. Their re-
port and our case both suggest that pleurodesis may fail
to promote proper adhesion around the injured thoracic
duct when it is difficult to inflate the remnant lung be-
cause a large amount of chylous discharge is located in
the dead space. If there are some chyle flow rate and
pressure, once the growth of fibrous adhesions following
pleurodesis blocks chylous discharge from entering the
chest tube, occult chyloma could arise despite a seem-
ingly successful pleurodesis with apparent cessation of
drainage.
Conclusion
This report presents the serious complications and limita-
tions of chemical pleurodesis and reviews the indications
for surgical intervention in postoperative chylothorax. Al-
though mediastinal chyloma is quite rare, it is important
to note that it can develop following chemical pleurodesis
treatment for chylothorax with a large amount of dis-
charge and that it can present symptoms due to com-
pression of the trachea and/or the esophagus.
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Fig. 3 Intra-operative image of the second surgery. When the thick capsule was incised, chyle began to spill out (a). thick capsule (b). The point
of chylous leakage near the azygos vein and vagus nerve (c). Repairing the leakage point using a Z-suture with 4–0 Prolene (d). Arrow mark indicating
the point of chylous leakage. Az indicating azygos vein, Va indicating vagus nerve
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